SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the six months ended June 30,
Second quarter total revenue of $1,021.5 million, up 54% year over year Number of customers contributing more than $100,000 in TTM revenue up 131% year over year Second quarter GAAP operating margin of 28.8% and non-GAAP operating margin of 41.6%
KUALA LUMPUR— A total of 14,886,006 individuals or 63.6 per cent of the adult population in Malaysia have completed both doses of the COVID-19 vaccination as of Monday, according to the COVID-19 Vaccine Supply Access Guarantee Special Committee (JKJAV)…
SINGAPORE— Singapore President Halimah Yacob on Tuesday received a credential from Malaysia’s 17th High Commissioner to Singapore, Dr Azfar Mohamad Mustafar.The president, who announced it in her latest Facebook update, also received credentials from t…
KUALA LUMPUR— Malaysia needs to push for progress in attracting foreign direct investment (FDI), particularly investors from the European Union (EU), the ASEAN Business Advisory Council (ASEAN-BAC) Malaysia said.The council said a consultation meeting …
KUALA LUMPUR— Malaysian Prime Minister Ismail Sabri Yaakob called on the people to embrace the theme of the 2021 National Day celebration, Caring Malaysia.In a post on his official Facebook on Tuesday, the prime minister stated that caring is a
